Camereyes

Deep-learning Imaging Platform to Prevent Diabetic Retinopathy

Health Tech & Life Sciences
Non Active, Jan 2020 ceased to operate
Seed Jerusalem, Israel Founded 2015
LinkedIn
Last updated 2026-06-18
Total raised
$950K
Last: 2018-04
Stage
Seed
Founded
2015
Headcount
1-10
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Camereyes has developed a simple end-to-end solution for detecting and monitoring diabetic retinopathy. The company's InSight leverages optics and deep-learning algorithms to provide a low-cost, fully automated solution in areas where professional eye care specialists may be scarce. InSight requires no special setup or skills, making it suitable for remote locations. Patients do not require pupil dilation; instead, they simply slip on a headset, and with the press of a button, high-quality fundus images are automatically captured and sent for storage in the cloud. Camereyes uses a network of professional reading centers with accredited graders supported by machine-learning algorithms to analyze the images and generate detailed reports, which are sent back within minutes to the point of care.

Funding history · 2 rounds · $950K total

2018-04
$300K
2015-12
$650K

Q&A

What is Camereyes' primary focus?
Camereyes focuses on developing a deep-learning imaging platform to prevent diabetic retinopathy.
When was Camereyes founded?
Camereyes was founded in February 2015.
What is the current status of Camereyes?
Camereyes is currently inactive, having ceased operations in January 2020.
How much funding has Camereyes raised in total?
Camereyes has raised a total of $950,000 USD.
When was Camereyes' last funding round and who participated?
Camereyes' last funding round was in April 2018, with participation from VLX Ventures.
What technology does Camereyes' InSight solution leverage?
Camereyes' InSight solution leverages optics and deep-learning algorithms for detecting and monitoring diabetic retinopathy.
Who are the founders of Camereyes?
The founders of Camereyes are Udi Gordon, Barak Azmon, and David Rosenblatt.

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Founder
LinkedIn ↗
David Rosenblatt
Founder · Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Platforms & InterfacesSoftwareMobileArtificial IntelligenceDeep LearningMachine LearningSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcarePatientsInsurance CompaniesProviders
Business model
B2B

Tags

diagnosticsdigital-healthcarenon-invasiveophthalmologyimagingmobile-applicationsmachine-learningartificial-intelligencechronic-patientsdiabetesdata-analyticssoftware-applicationsdeep-learningearly-detectionmedical-devicesclinicsinsurance-companiespreventionemrdoctorsoptronicsmedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)